[144] Nuvalent, Inc. SEC Filing

Rhea-AI Filing Summary

Nuvalent, Inc. (ticker: NUVL) filed a Form 144 reporting a proposed sale of 60,000 shares of Class A common stock through J.P. Morgan Securities LLC on NASDAQ, with an aggregate market value of $4,878,000 and an approximate sale date of 09/29/2025. The securities were acquired on 09/29/2025 through a stock option exercise and paid for in cash. The filing discloses two prior small sales by the same person in July 2025 totaling 20,000 shares for gross proceeds of $1,695,473. The filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider intends to sell 60,000 shares (~$4.88M) after exercising options; size is small relative to outstanding shares.

The filing shows an executive or insider exercised options and plans to sell 60,000 Class A shares via J.P. Morgan with an indicated market value of $4.878 million. Relative to the reported outstanding shares (66,669,583), this sale represents roughly 0.09% of the outstanding float, suggesting limited dilution or market impact. The July 2025 dispositions (20,000 shares) are disclosed, indicating recent incremental selling activity but not a material divestiture by itself.

Corporate Governance Expert

TL;DR: Transaction is a routine post-exercise sale under Rule 144; disclosure and certification comply with reporting expectations.

The notice indicates the securities were acquired by option exercise and will be sold in an open-market transaction through a broker. The filer signs the standard attestation about absence of undisclosed material adverse information and notes any prior three-month sales. From a governance perspective, the filing appears procedural and consistent with securities law requirements rather than signaling an extraordinary corporate development.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	J.P. Morgan Securities LLC 390 Madison Avenue 6th Floor New York NY 10017	60000	4878000	66669583	09/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	09/29/2025	Stock Option Exercise	Issuer			60000	09/29/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alexandra Balcom One Broadway, 14th Floor Cambridge MA 02142	Class A Common	07/15/2025	5300	442521
Alexandra Balcom One Broadway, 14th Floor Cambridge MA 02142	Class A Common	07/16/2025	14700	1250952

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Nuvalent's (NUVL) Form 144 report?

The Form 144 reports a proposed sale of 60,000 Class A shares through J.P. Morgan with an aggregate market value of $4,878,000 and an approximate sale date of 09/29/2025.

How were the 60,000 shares acquired according to the filing?

The filing states the shares were acquired on 09/29/2025 by a stock option exercise from the issuer and paid for in cash on that date.

Has the seller made other recent sales of NUVL stock?

Yes. The filer sold 5,300 shares on 07/15/2025 for $442,521 and 14,700 shares on 07/16/2025 for $1,250,952, totaling 20,000 shares in July 2025.

What percentage of Nuvalent's outstanding shares does this proposed sale represent?

The filing shows 66,669,583 shares outstanding; the proposed 60,000-share sale represents approximately 0.09% of outstanding shares.

Through which broker will the sale be executed?

The sale is to be executed through J.P. Morgan Securities LLC at the address listed in the filing.